Active Ingredient(s): Gefitinib
FDA Approved: * May 5, 2003
Pharm Company: * ASTRAZENECA
Category: Cancer

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances to gefitinib can arise through other mutations. It is marketed by AstraZeneca and Teva. It is on the World Health Organization's List of Essential Med... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Iressa 250 mg Oral Tablet
NDC: 0310-0482
Astrazeneca Pharmaceuticals Lp